GlycoMimetics (GLYC) Reports In-Line Q3 EPS

GlycoMimetics (NASDAQ: GLYC) reported Q3 EPS of ($0.14), in-line with the analyst estimate of ($0.14). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on GlycoMimetics (GLYC) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
• Incyte (INCY) Reiterated at Neutral by Cantor Fitzgerald After Management Chat